NS31492/NS/NINDS NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
1994	3
1995	2
1998	1
2000	2
2001	4
2002	1
2003	9
2004	8
2005	9
2006	5
2007	11
2008	6
2009	13
2010	13
2011	17
2012	9
2013	12
2014	11
2015	9
2016	4
2018	1
2021	1
2025	0

1

Batrakova EV, Gendelman HE, Kabanov AV. Batrakova EV, et al. Expert Opin Drug Deliv. 2011 Apr;8(4):415-33. doi: 10.1517/17425247.2011.559457. Epub 2011 Feb 24. Expert Opin Drug Deliv. 2011. PMID: 21348773 Free PMC article. Review.

2

Bridge between neuroimmunity and traumatic brain injury.

Kelso ML, Gendelman HE. Kelso ML, et al. Curr Pharm Des. 2014;20(26):4284-98. Curr Pharm Des. 2014. PMID: 24025052 Free PMC article. Review.

3

mda-7/IL-24: exploiting cancer's Achilles' heel.

Lebedeva IV, Sauane M, Gopalkrishnan RV, Sarkar D, Su ZZ, Gupta P, Nemunaitis J, Cunningham C, Yacoub A, Dent P, Fisher PB. Lebedeva IV, et al. Mol Ther. 2005 Jan;11(1):4-18. doi: 10.1016/j.ymthe.2004.08.012. Mol Ther. 2005. PMID: 15585401 Free article. Review.

4

mda-9/syntenin: recent insights into a novel cell signaling and metastasis-associated gene.

Sarkar D, Boukerche H, Su ZZ, Fisher PB. Sarkar D, et al. Pharmacol Ther. 2004 Nov;104(2):101-15. doi: 10.1016/j.pharmthera.2004.08.004. Pharmacol Ther. 2004. PMID: 15518882 Review.

5

AEG-1/MTDH/LYRIC, the beginning: initial cloning, structure, expression profile, and regulation of expression.

Lee SG, Kang DC, DeSalle R, Sarkar D, Fisher PB. Lee SG, et al. Adv Cancer Res. 2013;120:1-38. doi: 10.1016/B978-0-12-401676-7.00001-2. Adv Cancer Res. 2013. PMID: 23889986 Free PMC article. Review.

6

Immunomodulation as a neuroprotective and therapeutic strategy for Parkinson's disease.

Olson KE, Gendelman HE. Olson KE, et al. Curr Opin Pharmacol. 2016 Feb;26:87-95. doi: 10.1016/j.coph.2015.10.006. Epub 2015 Nov 11. Curr Opin Pharmacol. 2016. PMID: 26571205 Free PMC article. Review.

7

Immunization strategies for Parkinson's disease.

Ha D, Stone DK, Mosley RL, Gendelman HE. Ha D, et al. Parkinsonism Relat Disord. 2012 Jan;18 Suppl 1:S218-21. doi: 10.1016/S1353-8020(11)70067-0. Parkinsonism Relat Disord. 2012. PMID: 22166440 Review.

8

Synapses and Sisyphus: life without paraplegin.

Gelbard HA. Gelbard HA. J Clin Invest. 2004 Jan;113(2):185-7. doi: 10.1172/JCI20783. J Clin Invest. 2004. PMID: 14722610 Free PMC article. Review.

9

Role of excitatory amino acid transporter-2 (EAAT2) and glutamate in neurodegeneration: opportunities for developing novel therapeutics.

Kim K, Lee SG, Kegelman TP, Su ZZ, Das SK, Dash R, Dasgupta S, Barral PM, Hedvat M, Diaz P, Reed JC, Stebbins JL, Pellecchia M, Sarkar D, Fisher PB. Kim K, et al. J Cell Physiol. 2011 Oct;226(10):2484-93. doi: 10.1002/jcp.22609. J Cell Physiol. 2011. PMID: 21792905 Free PMC article. Review.

10

Human neural xenografts: progress in developing an in-vivo model to study human immunodeficiency virus (HIV) and human cytomegalovirus (HCMV) infection.

Epstein LG, Cvetkovich TA, Lazar ES, DiLoreto D, Saito Y, James H, del Cerro C, Kaneshima H, McCune JM, Britt WJ, et al. Epstein LG, et al. Adv Neuroimmunol. 1994;4(3):257-60. doi: 10.1016/s0960-5428(06)80264-0. Adv Neuroimmunol. 1994. PMID: 7874392 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

136 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

136 results

Results by year